$PHR
Phreesia, Inc. Stock $phr

$phr Overview Financials Valuation SEC Filings Company Website

2021 Q2 Form 10-Q Financial Statement

#000141240821000061 Filed on June 04, 2021

Income Statement

Concept	2021 Q2	2021 Q1	2020 Q2
Revenue	$48.29M	$41.81M	$33.40M
YoY Change	44.6%	27.41%	17.97%
Cost Of Revenue	$18.26M	$14.78M	$11.58M
YoY Change	57.68%	32.32%	5.75%
Gross Profit	$30.03M	$27.02M	$21.81M
YoY Change	37.7%	24.86%	25.63%
Gross Profit Margin	62.19%	64.63%	65.31%
Selling, General & Admin	$27.68M	$24.95M	$18.15M
YoY Change	52.49%	44.39%	30.16%
% of Gross Profit	92.18%	92.34%	83.24%
Research & Development	$8.054M	$6.360M	$5.005M
YoY Change	60.92%	30.86%	16.42%
% of Gross Profit	26.82%	23.54%	22.95%
Depreciation & Amortization	$4.948M	$4.250M	$3.621M
YoY Change	36.65%	16.44%	7.32%
% of Gross Profit	16.48%	15.73%	16.6%
Operating Expenses	$35.74M	$35.31M	$23.16M
YoY Change	54.31%	34.16%	26.93%
Operating Profit	-$10.65M	-$8.290M	-$4.966M
YoY Change	114.52%	77.44%	16.71%
Interest Expense	$258.0K	-$370.0K	$412.0K
YoY Change	-37.38%	-45.59%	-151.5%
% of Operating Profit
Other Income/Expense, Net	-$172.0K	$230.0K	-$1.035M
YoY Change	-83.38%	-182.14%	-56.37%
Pretax Income	-$10.83M	-$8.420M	-$6.001M
YoY Change	80.39%	49.56%	-9.45%
Income Tax	$149.0K	-$320.0K	$111.0K
% Of Pretax Income
Net Earnings	-$10.97M	-$8.100M	-$6.112M
YoY Change	79.55%	120.83%	-8.71%
Net Earnings / Revenue	-22.72%	-19.37%	-18.3%
Basic Earnings Per Share	-$0.24
Diluted Earnings Per Share	-$0.24	-$182.0K	-$163.8K
COMMON SHARES
Basic Shares Outstanding	45.42M shares	44.90M shares	37.68M shares
Diluted Shares Outstanding	45.42M shares

Balance Sheet

Concept	2021 Q2	2021 Q1	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$450.7M	$218.8M	$90.30M
YoY Change	399.09%	142.3%	1430.51%
Cash & Equivalents	$450.7M	$218.8M	$90.25M
Short-Term Investments
Other Short-Term Assets	$9.801M	$2.392M	$7.200M
YoY Change	36.13%	168.46%	56.52%
Inventory
Prepaid Expenses	$7.906M	$7.254M	$5.435M
Receivables	$29.96M	$29.05M	$24.22M
Other Receivables	$16.79M	$15.40M	$8.700M
Total Short-Term Assets	$507.2M	$272.3M	$130.4M
YoY Change	289.07%	106.99%	231.73%
LONG-TERM ASSETS
Property, Plant & Equipment	$27.57M	$26.66M	$14.99M
YoY Change	83.94%	84.03%	8.59%
Goodwill	$8.211M	$8.307M	$250.0K
YoY Change	3184.4%	3222.8%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.401M	$1.670M	$128.0K
YoY Change	994.53%	827.78%	-97.63%
Total Long-Term Assets	$53.97M	$54.40M	$30.93M
YoY Change	74.49%	99.85%	7.4%
TOTAL ASSETS
Total Short-Term Assets	$507.2M	$272.3M	$130.4M
Total Long-Term Assets	$53.97M	$54.40M	$30.93M
Total Assets	$561.2M	$326.7M	$161.3M
YoY Change	247.92%	105.76%	136.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$313.0K	$4.389M	$7.649M
YoY Change	-95.91%	-27.06%	1.99%
Accrued Expenses	$15.12M	$18.32M	$11.37M
YoY Change	32.9%	98.25%	57.97%
Deferred Revenue		$10.84M
YoY Change		100.67%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$4.103M	$4.900M	$336.0K
YoY Change	1121.13%	1186.09%	-83.2%
Total Short-Term Liabilities	$50.70M	$54.99M	$38.10M
YoY Change	33.05%	55.55%	6.14%
LONG-TERM LIABILITIES
Long-Term Debt	$5.532M	$6.500M	$19.47M
YoY Change	-71.59%	-66.57%	-45.92%
Other Long-Term Liabilities	$1.701M	$1.900M	$1.600M
YoY Change	6.31%		-72.88%
Total Long-Term Liabilities	$7.233M	$8.400M	$19.47M
YoY Change	-62.85%	-56.8%	-53.53%
TOTAL LIABILITIES
Total Short-Term Liabilities	$50.70M	$54.99M	$38.10M
Total Long-Term Liabilities	$7.233M	$8.400M	$19.47M
Total Liabilities	$57.93M	$63.36M	$61.39M
YoY Change	-5.63%	11.37%	-21.1%
SHAREHOLDERS EQUITY
Retained Earnings	-$322.8M	-$311.8M	-$290.6M
YoY Change	11.06%	9.59%
Common Stock	$503.0K	$449.0K	$376.0K
YoY Change	33.78%	22.68%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$6.110M	$4.965M	$846.0K
YoY Change	622.22%	1144.36%
Treasury Stock Shares	119.1K shares	99.52K shares
Shareholders Equity	$503.3M	$263.3M	$99.92M
YoY Change
Total Liabilities & Shareholders Equity	$561.2M	$326.7M	$161.3M
YoY Change	247.92%	105.76%	136.86%

Cashflow Statement

Concept	2021 Q2	2021 Q1	2020 Q2
OPERATING ACTIVITIES
Net Income	-$10.97M	-$8.100M	-$6.112M
YoY Change	79.55%	120.83%	-8.71%
Depreciation, Depletion And Amortization	$4.948M	$4.250M	$3.621M
YoY Change	36.65%	16.44%	7.32%
Cash From Operating Activities	-$5.473M	$4.080M	$1.903M
YoY Change	-387.6%	218.75%	-6.39%
INVESTING ACTIVITIES
Capital Expenditures	$3.983M	-$7.480M	$1.917M
YoY Change	107.77%	136.71%	45.89%
Acquisitions
YoY Change
Other Investing Activities		-$6.510M
YoY Change
Cash From Investing Activities	-$6.899M	-$13.99M	-$3.077M
YoY Change	124.21%	342.72%	12.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$245.8M		$0.00
YoY Change
Debt Paid & Issued, Net	$673.0K		$0.00
YoY Change			-100.0%
Cash From Financing Activities	$244.3M	-25.43M	$1.111M
YoY Change	21886.59%	-3201.22%	-78.05%
NET CHANGE
Cash From Operating Activities	-$5.473M	4.080M	$1.903M
Cash From Investing Activities	-$6.899M	-13.99M	-$3.077M
Cash From Financing Activities	$244.3M	-25.43M	$1.111M
Net Change In Cash	$231.9M	-35.34M	-$63.00K
YoY Change	-368193.65%	3233.96%	-101.44%
FREE CASH FLOW
Cash From Operating Activities	-$5.473M	$4.080M	$1.903M
Capital Expenditures	$3.983M	-$7.480M	$1.917M
Free Cash Flow	-$9.456M	$11.56M	-$14.00K
YoY Change	67442.86%	160.36%	-101.95%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q2	dei	Amendment Flag AmendmentFlag	false
CY2021Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001412408
CY2021Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2021Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-31
CY2021Q2	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q2	dei	Local Phone Number LocalPhoneNumber	654-7473
CY2021Q2	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
CY2021Q2	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	us-gaap:LongTermDebtAndCapitalLeaseObligations
CY2021Q2	dei	Document Type DocumentType	10-Q
CY2021Q2	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q2	dei	Document Period End Date DocumentPeriodEndDate	2021-04-30
CY2021Q2	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q2	dei	Entity File Number EntityFileNumber	001-38977
CY2021Q2	dei	Entity Registrant Name EntityRegistrantName	PHREESIA, INC.
CY2021Q2	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021Q2	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-2275479
CY2021Q2	dei	Entity Address Address Line1 EntityAddressAddressLine1	434 Fayetteville St
CY2021Q2	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1400
CY2021Q2	dei	Entity Address City Or Town EntityAddressCityOrTown	Raleigh
CY2021Q2	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
CY2021Q2	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	27601
CY2021Q2	dei	City Area Code CityAreaCode	888
CY2021Q2	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2021Q2	dei	Trading Symbol TradingSymbol	PHR
CY2021Q2	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q2	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q2	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021Q2	dei	Entity Small Business EntitySmallBusiness	false
CY2021Q2	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q2	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	50519622	shares
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	450680000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	218781000	USD
CY2021Q2	us-gaap	Settlement Assets Current SettlementAssetsCurrent	16788000	USD
CY2021Q1	us-gaap	Settlement Assets Current SettlementAssetsCurrent	15488000	USD
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	666000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	699000	USD
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	29964000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	29052000	USD
CY2021Q2	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	1895000	USD
CY2021Q1	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	1693000	USD
CY2021Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7906000	USD
CY2021Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7254000	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	507233000	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	272268000	USD
CY2021Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	43442000	USD
CY2021Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	40148000	USD
CY2021Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	25068000	USD
CY2021Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	26660000	USD
CY2021Q2	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	26998000	USD
CY2021Q1	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	25476000	USD
CY2021Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	11225000	USD
CY2021Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	10476000	USD
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2497000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2654000	USD
CY2021Q2	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	2438000	USD
CY2021Q1	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	1248000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	653000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	525000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2597000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2725000	USD
CY2021Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	533000	USD
CY2021Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	658000	USD
CY2021Q2	us-gaap	Goodwill Goodwill	8211000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	8307000	USD
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1401000	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1670000	USD
CY2021Q2	us-gaap	Assets Assets	561203000	USD
CY2021Q1	us-gaap	Assets Assets	326666000	USD
CY2021Q2	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	16788000	USD
CY2021Q1	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	15488000	USD
CY2021Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	4103000	USD
CY2021Q1	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	4864000	USD
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1153000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1087000	USD
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	313000	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	4389000	USD
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	15116000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	18324000	USD
CY2021Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	13223000	USD
CY2021Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	10838000	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	50696000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	54990000	USD
CY2021Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	5532000	USD
CY2021Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	6471000	USD
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1701000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1899000	USD
CY2021Q2	us-gaap	Liabilities Liabilities	57929000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	63360000	USD
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50270229	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	44880883	shares
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	503000	USD
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	449000	USD
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	831632000	USD
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	579599000	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-322751000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-311777000	USD
CY2021Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	119138	shares
CY2021Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	99520	shares
CY2021Q2	us-gaap	Treasury Stock Value TreasuryStockValue	6110000	USD
CY2021Q1	us-gaap	Treasury Stock Value TreasuryStockValue	4965000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	503274000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	263306000	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	561203000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	326666000	USD
CY2021Q2	us-gaap	Revenues Revenues	48291000	USD
CY2020Q2	us-gaap	Revenues Revenues	33396000	USD
CY2021Q2	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	8534000	USD
CY2020Q2	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	4734000	USD
CY2021Q2	phr	Payment Processing Expense PaymentProcessingExpense	9725000	USD
CY2020Q2	phr	Payment Processing Expense PaymentProcessingExpense	6848000	USD
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	15012000	USD
CY2020Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	9434000	USD
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8054000	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5005000	USD
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12671000	USD
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8720000	USD
CY2021Q2	us-gaap	Depreciation Depreciation	3297000	USD
CY2020Q2	us-gaap	Depreciation Depreciation	2268000	USD
CY2021Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1651000	USD
CY2020Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1353000	USD
CY2021Q2	us-gaap	Costs And Expenses CostsAndExpenses	58944000	USD
CY2020Q2	us-gaap	Costs And Expenses CostsAndExpenses	38362000	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-10653000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4966000	USD
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	66000	USD
CY2020Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-715000	USD
CY2021Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-238000	USD
CY2020Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-320000	USD
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-172000	USD
CY2020Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1035000	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10825000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6001000	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	149000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	111000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-10974000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-6112000	USD
CY2021Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.24
CY2020Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.16
CY2021Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	45416431	shares
CY2020Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	37308084	shares
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	101865000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-6112000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2872000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1736000	USD
CY2020Q2	phr	Treasury Stock From Option Exercises TreasuryStockFromOptionExercises	447000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	99914000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	263306000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-10974000	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5774000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	500000	USD
CY2021Q2	phr	Treasury Stock From Option Exercises TreasuryStockFromOptionExercises	1145000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	245813000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	503274000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-10974000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-6112000	USD
CY2021Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4948000	USD
CY2020Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3621000	USD
CY2021Q2	us-gaap	Share Based Compensation ShareBasedCompensation	5774000	USD
CY2020Q2	us-gaap	Share Based Compensation ShareBasedCompensation	2872000	USD
CY2021Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	72000	USD
CY2020Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	126000	USD
CY2021Q2	phr	Cost Of Phreesia Hardware Purchased By Others CostOfPhreesiaHardwarePurchasedByOthers	135000	USD
CY2020Q2	phr	Cost Of Phreesia Hardware Purchased By Others CostOfPhreesiaHardwarePurchasedByOthers	172000	USD
CY2021Q2	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	575000	USD
CY2020Q2	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	525000	USD
CY2021Q2	phr	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	256000	USD
CY2020Q2	phr	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	389000	USD
CY2021Q2	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	125000	USD
CY2020Q2	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	56000	USD
CY2021Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	912000	USD
CY2020Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2245000	USD
CY2021Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	809000	USD
CY2020Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1614000	USD
CY2021Q2	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	1967000	USD
CY2020Q2	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	714000	USD
CY2021Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1068000	USD
CY2020Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-998000	USD
CY2021Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3678000	USD
CY2020Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1871000	USD
CY2021Q2	phr	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-335000	USD
CY2020Q2	phr	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-502000	USD
CY2021Q2	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	2385000	USD
CY2020Q2	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1228000	USD
CY2021Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5473000	USD
CY2020Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1903000	USD
CY2021Q2	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	2916000	USD
CY2020Q2	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1160000	USD
CY2021Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3983000	USD
CY2020Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1917000	USD
CY2021Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6899000	USD
CY2020Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3077000	USD
CY2021Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	245813000	USD
CY2020Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2021Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1356000	USD
CY2020Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1736000	USD
CY2021Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1145000	USD
CY2020Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2021Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	30000	USD
CY2020Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2021Q2	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1050000	USD
CY2020Q2	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	525000	USD
CY2021Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	673000	USD
CY2020Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2021Q2	phr	Payment Of Loan Facility Fees PaymentOfLoanFacilityFees	0	USD
CY2020Q2	phr	Payment Of Loan Facility Fees PaymentOfLoanFacilityFees	100000	USD
CY2021Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	244271000	USD
CY2020Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1111000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	231899000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-63000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	218781000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	90315000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	450680000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	90252000	USD
CY2021Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	81000	USD
CY2020Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3185000	USD
CY2021Q2	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	203000	USD
CY2020Q2	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	827000	USD
CY2021Q2	phr	Deferred Issuance Costs Included In Accounts Payable And Accrued Expenses DeferredIssuanceCostsIncludedInAccountsPayableAndAccruedExpenses	362000	USD
CY2020Q2	phr	Deferred Issuance Costs Included In Accounts Payable And Accrued Expenses DeferredIssuanceCostsIncludedInAccountsPayableAndAccruedExpenses	0	USD
CY2021Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	351000	USD
CY2020Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	791000	USD
CY2021Q2	us-gaap	Interest Paid Net InterestPaidNet	156000	USD
CY2020Q2	us-gaap	Interest Paid Net InterestPaidNet	306000	USD
CY2021Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	5175000	shares
CY2021Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	50.00
CY2021Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	245813000	USD
CY2021Q2	phr	Estimated Number Of Months The Company Have Sufficient To Fund Its Operations EstimatedNumberOfMonthsTheCompanyHaveSufficientToFundItsOperations	P12M
CY2021Q2	us-gaap	Basis Of Accounting BasisOfAccounting	Basis of presentation<div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a) Consolidated financial statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("U.S. GAAP") and include the accounts of Phreesia, Inc., its branch operation in Canada and its subsidiary QueueDr Inc. (collectively, the "Company").</span></div><div style="margin-top:3pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b) Fiscal year</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s fiscal year ends on January 31. References to fiscal 2022 and 2021 refer to the fiscal years ended January 31, 2022 and January 31, 2021, respectively.</span></div><div><span><br/></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c) Unaudited interim financial statements</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited interim consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP") and applicable rules and regulations of the Securities and Exchange Commission ("SEC") regarding interim financial reporting. In the opinion of management, the accompanying unaudited interim consolidated financial statements reflect all adjustments, which include normal recurring adjustments, necessary for the fair statement of the Company’s interim financial position as of April 30, 2021 and the results of its operations, changes in its stockholders' equity and its cash flows for the periods ended April 30, 2021 and 2020. Certain information and note disclosures normally included in the financial statements </span></div>prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations.The results for the interim periods are not necessarily indicative of results to be expected for the full year, any other interim periods, or any future year or period. The Company’s management believes that the disclosures herein are adequate to make the information presented not misleading when read in conjunction with the audited financial statements and accompanying notes for the fiscal year ended January 31, 2021.
CY2021Q2	us-gaap	Fiscal Period FiscalPeriod	Fiscal yearThe Company’s fiscal year ends on January 31. References to fiscal 2022 and 2021 refer to the fiscal years ended January 31, 2022 and January 31, 2021, respectively.
CY2021Q2	us-gaap	Use Of Estimates UseOfEstimates	Use of estimatesThe preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and assumptions on historical experience, known trends and events and various other factors that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments. Although management believes its estimates and assumptions are reasonable under the circumstances at the time they are made, they are based upon information available at the time they are made. Management evaluates the estimates and assumptions on an ongoing basis and, if necessary, makes adjustments. Actual results could differ from those estimates made under different assumptions or circumstances. The most significant assumptions and estimates relate to the allowance for doubtful accounts, capitalized internal-use software, the determination of the useful lives of property and equipment, the fair value of securities underlying stock-based compensation, the fair value of identifiable assets and liabilities in a business acquisition, and the realization of deferred tax assets.
CY2021Q2	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentrations of credit riskFinancial instruments which potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable and settlement assets. The Company’s cash and cash equivalents are held by established financial institutions. The Company does not require collateral from its customers and generally requires payment within 30 to 60 days of billing. Settlement assets are amounts due from well-established payment processing companies and normally take <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMDVkZDFiMjQ3YjQ3MTM4OGU2ZTE4MzliY2FlMGVhL3NlYzo2MTA1ZGQxYjI0N2I0NzEzODhlNmUxODM5YmNhZTBlYV81Mi9mcmFnOjM1YjI5YmM2ZmY2NjQ4NGQ5MDc0ZGUxMmU3OThhM2VhL3RleHRyZWdpb246MzViMjliYzZmZjY2NDg0ZDkwNzRkZTEyZTc5OGEzZWFfMjE5OTAyMzI2NjA3Ng_4c695138-4724-4832-9ed7-6af46ea246bd">one</span> or <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYxMDVkZDFiMjQ3YjQ3MTM4OGU2ZTE4MzliY2FlMGVhL3NlYzo2MTA1ZGQxYjI0N2I0NzEzODhlNmUxODM5YmNhZTBlYV81Mi9mcmFnOjM1YjI5YmM2ZmY2NjQ4NGQ5MDc0ZGUxMmU3OThhM2VhL3RleHRyZWdpb246MzViMjliYzZmZjY2NDg0ZDkwNzRkZTEyZTc5OGEzZWFfMjE5OTAyMzI2NjA3Nw_664c71f5-668c-4ac5-a088-9495d365f637">two</span> business days to settle which mitigates the associated risk of concentration. The Company utilizes one third-party payment processor.The Company’s customers are primarily physician’s offices located in the United States and pharmaceutical companies.
CY2021Q2	phr	Number Of Third Party Payment Processors NumberOfThirdPartyPaymentProcessors	1	processor
CY2021Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4086000	USD
CY2021Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8946000	USD
CY2021Q2	phr	Accrued Processing Fee AccruedProcessingFee	3343000	USD
CY2021Q1	phr	Accrued Processing Fee AccruedProcessingFee	2853000	USD
CY2021Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7687000	USD
CY2021Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6525000	USD
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	15116000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	18324000	USD
CY2021Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	68510000	USD
CY2021Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	66808000	USD
CY2021Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	43442000	USD
CY2021Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	40148000	USD
CY2021Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	25068000	USD
CY2021Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	26660000	USD
CY2021Q2	us-gaap	Depreciation Depreciation	3297000	USD
CY2020Q2	us-gaap	Depreciation Depreciation	2268000	USD
CY2021Q2	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	2272000	USD
CY2020Q2	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	1756000	USD
CY2021Q2	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	1523000	USD
CY2020Q2	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	1293000	USD
CY2021Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	11225000	USD
CY2021Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	10476000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3250000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3250000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	653000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	525000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2597000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2725000	USD
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	128000	USD
CY2020Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	60000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	381000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	508000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	494000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	410000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	804000	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2597000	USD
CY2021Q2	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
CY2021Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021Q2	us-gaap	Goodwill Goodwill	8211000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	8307000	USD
CY2021Q2	us-gaap	Billed Contract Receivables BilledContractReceivables	29921000	USD
CY2021Q1	us-gaap	Billed Contract Receivables BilledContractReceivables	28464000	USD
CY2021Q2	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	709000	USD
CY2021Q1	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	1287000	USD
CY2021Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	30630000	USD
CY2021Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	29751000	USD
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	666000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	699000	USD
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	29964000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	29052000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	699000	USD
CY2021Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	13000	USD
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	46000	USD
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	666000	USD
CY2021Q2	phr	Prepaid Software And Business Systems PrepaidSoftwareAndBusinessSystems	3734000	USD
CY2021Q1	phr	Prepaid Software And Business Systems PrepaidSoftwareAndBusinessSystems	2322000	USD
CY2021Q2	phr	Prepaid Data Center Expenses PrepaidDataCenterExpenses	1905000	USD
CY2021Q1	us-gaap	Prepaid Insurance PrepaidInsurance	1311000	USD
CY2021Q2	phr	Other Prepaid Expenses And Other Current Assets OtherPrepaidExpensesAndOtherCurrentAssets	1604000	USD
CY2021Q1	phr	Prepaid Data Center Expenses PrepaidDataCenterExpenses	1211000	USD
CY2021Q2	us-gaap	Prepaid Insurance PrepaidInsurance	663000	USD
CY2021Q1	phr	Other Prepaid Expenses And Other Current Assets OtherPrepaidExpensesAndOtherCurrentAssets	2410000	USD
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7906000	USD
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7254000	USD
CY2021Q2	us-gaap	Hosting Arrangement Service Contract Implementation Cost Capitalized Before Accumulated Amortization HostingArrangementServiceContractImplementationCostCapitalizedBeforeAccumulatedAmortization	949000	USD
CY2021Q1	us-gaap	Hosting Arrangement Service Contract Implementation Cost Capitalized Before Accumulated Amortization HostingArrangementServiceContractImplementationCostCapitalizedBeforeAccumulatedAmortization	893000	USD
CY2021Q2	us-gaap	Hosting Arrangement Service Contract Implementation Cost Capitalized Accumulated Amortization HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization	34000	USD
CY2021Q1	us-gaap	Hosting Arrangement Service Contract Implementation Cost Capitalized Accumulated Amortization HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization	23000	USD
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	66000	USD
CY2021Q2	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	65000	USD
CY2020Q2	us-gaap	Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments	715000	USD
CY2020Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-715000	USD
CY2021Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1287000	USD
CY2021Q2	us-gaap	Contract With Customer Asset Reclassified To Receivable ContractWithCustomerAssetReclassifiedToReceivable	1005000	USD
CY2021Q2	us-gaap	Contract With Customer Asset Purchase ContractWithCustomerAssetPurchase	427000	USD
CY2021Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	709000	USD
CY2021Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	10838000	USD
CY2021Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	8626000	USD
CY2021Q2	phr	Contract With Customer Liability Current Period Revenue Recognized ContractWithCustomerLiabilityCurrentPeriodRevenueRecognized	4340000	USD
CY2021Q2	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	15351000	USD
CY2021Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	13223000	USD
CY2021Q2	us-gaap	Capitalized Contract Cost Amortization Period CapitalizedContractCostAmortizationPeriod	P3Y
CY2021Q2	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	575000	USD
CY2020Q2	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	525000	USD
CY2020Q2	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0	USD
CY2021Q2	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0	USD
CY2021Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	2941000	USD
CY2021Q2	phr	Deferred Contract Acquisition Costs DeferredContractAcquisitionCosts	1967000	USD
CY2021Q2	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	575000	USD
CY2021Q2	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	4333000	USD
CY2021Q2	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	1895000	USD
CY2021Q2	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	2438000	USD
CY2021Q2	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	4333000	USD
CY2021Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	8854000	USD
CY2021Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	9702000	USD
CY2021Q2	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	9635000	USD
CY2021Q1	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	11335000	USD
CY2021Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	4103000	USD
CY2021Q1	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	4864000	USD
CY2021Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	5532000	USD
CY2021Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	6471000	USD
CY2021Q2	phr	Long Term Debt And Finance Lease Obligations Repayments Of Principal In Remainder Of Fiscal Year LongTermDebtAndFinanceLeaseObligationsRepaymentsOfPrincipalInRemainderOfFiscalYear	3329000	USD
CY2021Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	506000	USD
CY2021Q2	phr	Finance Lease Liability Payments Remainder Of Fiscal Year Discounted Obligation FinanceLeaseLiabilityPaymentsRemainderOfFiscalYearDiscountedObligation	2823000	USD
CY2021Q2	phr	Long Term Debt And Finance Lease Obligations Maturities Repayments Of Principal In Year One LongTermDebtAndFinanceLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearOne	3486000	USD
CY2021Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	229000	USD
CY2021Q2	phr	Finance Lease Liability Payments Due Year One Discounted Obligation FinanceLeaseLiabilityPaymentsDueYearOneDiscountedObligation	3257000	USD
CY2021Q2	phr	Long Term Debt And Finance Lease Obligations Maturities Repayments Of Principal In Year Two LongTermDebtAndFinanceLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo	2351000	USD
CY2021Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	46000	USD
CY2021Q2	phr	Finance Lease Liability Payments Due Year Two Discounted Obligation FinanceLeaseLiabilityPaymentsDueYearTwoDiscountedObligation	2305000	USD
CY2021Q2	phr	Long Term Debt And Finance Lease Obligations Maturities Repayments Of Principal In Year Three LongTermDebtAndFinanceLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree	313000	USD
CY2021Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2021Q2	phr	Finance Lease Liability Payments Due Year Three Discounted Obligation FinanceLeaseLiabilityPaymentsDueYearThreeDiscountedObligation	313000	USD
CY2021Q2	phr	Long Term Debt And Finance Lease Obligations Maturities Repayments Of Principal In Year Four LongTermDebtAndFinanceLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour	156000	USD
CY2021Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2021Q2	phr	Finance Lease Liability Payments Due Year Four Discounted Obligation FinanceLeaseLiabilityPaymentsDueYearFourDiscountedObligation	156000	USD
CY2021Q2	phr	Long Term Debt And Lease Obligations Gross Including Original Issue Discount LongTermDebtAndLeaseObligationsGrossIncludingOriginalIssueDiscount	9635000	USD
CY2021Q2	us-gaap	Long Term Debt LongTermDebt	781000	USD
CY2021Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	8854000	USD
CY2021Q2	us-gaap	Interest Expense InterestExpense	258000	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	412000	USD
CY2021Q2	us-gaap	Interest Income Operating InterestIncomeOperating	20000	USD
CY2020Q2	us-gaap	Interest Income Operating InterestIncomeOperating	92000	USD
CY2021Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-238000	USD
CY2020Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-320000	USD
CY2019Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2019Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	5175000	shares
CY2021Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	50.00
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	245813000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	3211354	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	4.67
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	167067	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.99
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	23273	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	6.90
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	3021014	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	4.74
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y4M20D
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	207984000	USD
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2227119	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y7M9D
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	142005000	USD
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	78707	shares
CY2021Q2	phr	Share Based Compensation Arrangements By Share Based Payment Award Options Vested In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice	0
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	9700000	USD
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	50472000	USD
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2497000	USD
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1153000	USD
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1701000	USD
CY2021Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	2854000	USD
CY2021Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1055000	USD
CY2021Q2	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	20139000	USD
CY2021Q2	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	11444000	USD
CY2021Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	8695000	USD
CY2021Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3713000	USD
CY2021Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	5141000	USD
CY2021Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	8854000	USD
CY2021Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2021Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.035
CY2021Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2021Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.041
CY2021Q2	phr	Operating Lease Cost Excluding Variable Lease Cost OperatingLeaseCostExcludingVariableLeaseCost	256000	USD
CY2021Q2	us-gaap	Variable Lease Cost VariableLeaseCost	67000	USD
CY2021Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	323000	USD
CY2021Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	102000	USD
CY2021Q2	phr	Finance Lease Cost FinanceLeaseCost	1157000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	940000	USD
CY2021Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	3050000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1187000	USD
CY2021Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	3427000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	794000	USD
CY2021Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	2365000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	52000	USD
CY2021Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	328000	USD
CY2021Q2	phr	Lessee Operating Lease Liability To Be Paid After Year Three LesseeOperatingLeaseLiabilityToBePaidAfterYearThree	0	USD
CY2021Q2	phr	Finance Lease Liability To Be Paid After Year Three FinanceLeaseLiabilityToBePaidAfterYearThree	158000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2973000	USD
CY2021Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	9328000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	119000	USD
CY2021Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	474000	USD
CY2021Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	2854000	USD
CY2021Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	8854000	USD
CY2021Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	233000	USD
CY2021Q2	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	102000	USD
CY2021Q2	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1050000	USD
CY2021Q2	phr	Lease Payments LeasePayments	1385000	USD
CY2021Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	81000	USD
CY2021Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	203000	USD
CY2021Q2	phr	Right Of Use Asset Obtained In Exchange For Lease Liability RightOfUseAssetObtainedInExchangeForLeaseLiability	284000	USD
CY2021Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	233000	USD
CY2021Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1291000	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	149000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	111000	USD
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.014
CY2020Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.019
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-10974000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-6112000	USD
CY2021Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	45416431	shares
CY2020Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	37308084	shares
CY2021Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.24
CY2020Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.16
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5727577	shares
CY2020Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6480906	shares

Files In Submission

Name	View Source	Status
0001412408-21-000061-index-headers.html	Edgar Link	pending
0001412408-21-000061-index.html	Edgar Link	pending
0001412408-21-000061.txt	Edgar Link	pending
0001412408-21-000061-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_1.jpg	Edgar Link	pending
image_2.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
phr-20210430.htm	Edgar Link	pending
phr-20210430.xsd	Edgar Link	pending
phr-20210430ex103.htm	Edgar Link	pending
phr-20210430ex104.htm	Edgar Link	pending
phr-20210430ex105.htm	Edgar Link	pending
phr-20210430ex311.htm	Edgar Link	pending
phr-20210430ex312.htm	Edgar Link	pending
phr-20210430ex321.htm	Edgar Link	pending
phr-20210430ex322.htm	Edgar Link	pending
phr-20210430_cal.xml	Edgar Link	unprocessable
phr-20210430_def.xml	Edgar Link	unprocessable
phr-20210430_htm.xml	Edgar Link	completed
phr-20210430_lab.xml	Edgar Link	unprocessable
phr-20210430_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PHR
Phreesia, Inc. Stock $phr

2021 Q2 Form 10-Q Financial Statement

#000141240821000061 Filed on June 04, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PHR Phreesia, Inc. Stock $phr

2021 Q2 Form 10-Q Financial Statement

#000141240821000061 Filed on June 04, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PHR
Phreesia, Inc. Stock $phr